The Affiliated Nanjing Drum Tower Hospital Of Nanjing University Medical School
Clinical trials sponsored by The Affiliated Nanjing Drum Tower Hospital Of Nanjing University Medical School, explained in plain language.
-
Can a diabetes drug boost weight loss after surgery?
Disease control CompletedThis study looked at whether liraglutide, a drug used for diabetes and weight loss, can help people who are still obese 6 months after metabolic surgery lose more weight. 100 participants received liraglutide injections for 24 weeks along with diet and exercise guidance. The goal…
Phase: PHASE4 • Sponsor: The Affiliated Nanjing Drum Tower Hospital of Nanjing University Medical School • Aim: Disease control
Last updated Jun 27, 2026 09:00 UTC
-
New hope for Hard-to-Control blood pressure: finerenone shows promise
Disease control CompletedThis study tested a drug called finerenone in 55 adults with primary aldosteronism, a condition where the adrenal glands make too much aldosterone, leading to high blood pressure. The goal was to see if finerenone can safely lower blood pressure over 12 weeks. Participants starte…
Phase: PHASE4 • Sponsor: The Affiliated Nanjing Drum Tower Hospital of Nanjing University Medical School • Aim: Disease control
Last updated Jun 26, 2026 16:02 UTC
-
10,000 seniors studied to predict fatty liver dangers
Knowledge-focused CompletedThis study looked at 10,000 older adults (age 60+) with fatty liver disease to find out what increases their risk for serious liver problems like scarring, cirrhosis, or liver cancer. Researchers used medical records and yearly check-ups to build a computer model that predicts th…
Sponsor: The Affiliated Nanjing Drum Tower Hospital of Nanjing University Medical School • Aim: Knowledge-focused
Last updated Jun 27, 2026 12:09 UTC